91ÑÇÉ«´«Ã½

Jobs

‘We're all a bunch of weirdos doing our stuff’

5 questions with Charles Sanders of XBiotech
Martina G. Efeyini
May 20, 2022

talked to 91ÑÇÉ«´«Ã½ Today about his experience working on biopharmaceutical products at , where he started as a research associate in March, and , where he worked for more than three years after earning his bachelor’s in biochemistry. This interview has been condensed and edited.

Charles Sanders

Current position: Research associate II at XBiotech

Career path: Bachelor’s in biochemistry, Texas State University

First job outside of academia: Testing technologist at Grifols

Favorite molecule or protein: "I actually do have a favorite one because I love its name. It's polytetrafluoroethylene. I just like the way it rolls off."

What made you decide to focus on products?

Both Grifols and XBiotech manufacture medicine, and I enjoy pharmaceuticals. I just really enjoy helping people. I’ve been wanting to make medicines for a long time. I feel like it’s a good contribution to the world. Before I was part of it, but now I’m really part of it because I’m in the research department at XBiotech. I actually get to start everything and test things out.

Grifols is one of the largest producers of plasma medicines in the world. Tell me about your work there as a testing technologist.

It was an entry-level position. There are people who have been there for forever. Also, there are people coming later in life. But generally they like to hire people straight out of college.

We would take the plasma that got sent to us. We would screen it using different biochemical assays, like the ELISA. We had something called the C8000 that would test for total protein concentration and concentration of alanine aminotransferase as a test for donor liver health. We also tested for syphilis and rabies — all kinds of fun stuff.

You have a new role at XBiotech as a research associate. Tell me about that.

I’m still in the training phase. I have to find out where everything is and exactly what’s going on, but I've become pretty independent. I’ve been doing mostly gel runs and western blots. Basically, doing protein analysis, checking for different proteins, and seeing if antibodies will bind to them because we’re looking for specific things.

There’s different departments: There’s cell lines — they do all the cloning. There’s biochemistry, there’s animal models — all kinds of teams — but I’m specifically in the in vitro testing.

I feel at home. We’re all a bunch of weirdos doing our stuff.

How did you wind up at XBiotech?

I think the three years of experience I got at Grifols really helped me, and I think that’s what got me drafted to this position. I did undergrad research, and the scientist who leads my team recognized my principal investigator’s name. And then he saw what I’d been doing at Grifols.

He said that, because of COVID-19, most people were doing their master’s degrees online, but they don’t have any actual research experience. So I outranked a lot of master’s students because I have real-world experience. So, I think it was all worth it.

What advice do you have for students who are interested in industry?

Do it if you want to experience the world. I think you should explore the world and learn how the Food and Drug Administration works and good manufacturing practices.

If you want to stay in academia, you can do that. But I actually think academia is more stressful. I felt like, if I just stayed in academia, I’d be losing potential to learn the world.

Enjoy reading 91ÑÇÉ«´«Ã½ Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Martina G. Efeyini

Martina G. Efeyini is a science communicator, STEM education advocate and former 91ÑÇÉ«´«Ã½ Today careers columnist.

Featured jobs

from the

Get the latest from 91ÑÇÉ«´«Ã½ Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Careers

Careers highlights or most popular articles

Exploring lipid metabolism: A journey through time and innovation
91ÑÇÉ«´«Ã½ Annual Meeting

Exploring lipid metabolism: A journey through time and innovation

April 4, 2025

Recent lipid metabolism research has unveiled critical insights into lipid–protein interactions, offering potential therapeutic targets for metabolic and neurodegenerative diseases. Check out the latest in lipid science at the 91ÑÇÉ«´«Ã½ annual meeting.

Hidden strengths of an autistic scientist
Essay

Hidden strengths of an autistic scientist

April 3, 2025

Navigating the world of scientific research as an autistic scientist comes with unique challenges —microaggressions, communication hurdles and the constant pressure to conform to social norms, postbaccalaureate student Taylor Stolberg writes.

Upcoming opportunities
Announcement

Upcoming opportunities

April 2, 2025

The countdown to #91ÑÇÉ«´«Ã½25 is on! Visit our annual meeting website to start adding special sessions, keynote lectures, scientific symposia and more to your personal schedule.

Melissa Moore to speak at 91ÑÇÉ«´«Ã½ 2025
91ÑÇÉ«´«Ã½ Annual Meeting

Melissa Moore to speak at 91ÑÇÉ«´«Ã½ 2025

April 2, 2025

Richard Silverman and Melissa Moore are the featured speakers at the 91ÑÇÉ«´«Ã½ annual meeting to be held April 12-15 in Chicago.

Engineering the future with synthetic biology
91ÑÇÉ«´«Ã½ Annual Meeting

Engineering the future with synthetic biology

March 31, 2025

Learn about the 91ÑÇÉ«´«Ã½ 2025 symposium on synthetic biology, featuring applications to better human and environmental health.

Host vs. pathogen and the molecular arms race
91ÑÇÉ«´«Ã½ Annual Meeting

Host vs. pathogen and the molecular arms race

March 28, 2025

Learn about the 91ÑÇÉ«´«Ã½ 2025 symposium on host–pathogen interactions, to be held Sunday, April 13 at 1:50 p.m.